Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Farxiga Lawsuit Claims Users Would Have Avoided Diabetes Drug If Warned of Fournier’s Gangrene Risks April 5, 2021 Irvin Jackson Add Your Comments AstraZeneca faces a product liability lawsuit over the failure to warn about the risk of painful and debilitating groin infections from Farxiga, indicating a Missouri man would have avoided the new-generation diabetes treatment if the drug maker had disclosed the risk of Fournier’s gangrene associated with Farxiga. The complaint (PDF) was filed by Micheal Tuschhoff and his wife, Rona, in Delaware Superior Court on March 10, alleging the rare groin infection experienced following use of Farxiga left him with a necrotic scrotal abscess and other painful injuries. Tuschhoff was first prescribed Farxiga in 2014, which is part of a new class of diabetes treatments known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. After developing an infection, he was required to undergo genital gangrene surgery in June 2017, with extensive hospitalization and wound care. He then had to be hospitalized again in September 2018, for an incision and drainage of a scrotal wall abscess. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The lawsuit alleges AstraZeneca knew or should have known about the risk of necrotizing fasciitis of the genitals which may result from Farxiga, based on basic principals of infections disease science and data available to the drug maker. However, warnings were not provided to users or the medical community at the time Tuschhoff was prescribed the medication. “Plaintiff’s injuries were preventable and resulted directly from Defendants’ failure and refusal to conduct proper safety studies, failure to properly test Farxiga, and failure to properly assess and publicize alarming safety signals,” the lawsuit states. “Defendants actively suppressed information revealing serious and life-threatening risks with Farxiga, promoted Farxiga for weight loss, and willfully and wantonly failed to provide adequate instructions and warnings and made misrepresentations concerning the nature and safety of Farxiga. This conduct and the product defects complained of brought about and/or were substantial factors in bringing about and exacerbating Plaintiff’s injuries.” About a year after Tuschhoff’s devastating injuries surfaced, the FDA required the makers of Farxiga and other SGLT2 inhibitors to add new warnings about the risk of flesh-eating groin infections in August 2018, after an analysis identified cases of Fournier’s gangrene among users. Consumers were advised to seek immediate medical attention if they experienced any symptoms of tenderness, redness or swelling of the genitals, and doctors were urged to discontinue use of the drug if problems were identified and start immediate antibiotic treatments. The case filed by Tuschhoff joins a growing number of similar Farxiga lawsuits over Fournier’s gangrene infections filed in recent months by former users of the diabetes drug, each raising similar allegations that users would have avoided the diabetes drug if earlier warnings and information had been provided about the potential risks. Tags: AstraZeneca, Diabetes, Diabetes Drug, Farxiga, Fournier's Gangrene, Infection Image Credit: | More Lawsuit Stories Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge June 13, 2025 Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis June 13, 2025 AFFF Chemicals May Accelerate Spread of Cancer, Reduce Drug Effectiveness: Study June 13, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 3 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025) Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: 4 days ago) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025) Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: 4 days ago) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)
Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (Posted: 3 days ago) A court status report indicates that Depo-Provera lawsuits are being filed at a rapid pace, and generic manufacturers are likely to be dismissed from the litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)Lawsuit Indicates Depo-Provera Meningioma Growth Risks Created Constant Distress (06/06/2025)Lawsuit Alleges Intracranial Meningioma From Depo-Provera Resulted in Need for Lifelong Medical Monitoring (05/28/2025)
Reckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (Posted: 4 days ago) A class action lawsuit filed against the makers of Enfamil say the company misled investors by concealing the fact that the cow’s milk-based infant formula increased the risk of NEC. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITNEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)Expert Witnesses Linking Baby Formula and NEC Cleared for Trial, Despite Dismissal of First Bellwether Lawsuit (05/05/2025)
Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (Posted: 4 days ago) A federal judge has directed hair relaxer manufacturers to select a replacement case for the bellwether trial pool, following the plaintiff’s voluntary dismissal of one of the previously selected lawsuits. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (05/21/2025)Formaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)